CARE: Lupus



Start Date:


End Date:




Max Credits:


Credit Type:




Program Information

This online self-assessment tool is designed to test the rheumatology knowledge base of physicians. This module consists of 30 case-based questions with answer rationales, images, and educational reference links.


Learning Objectives
Upon completion of this activity, participants should be able to:

  • Recognize the varied clinical manifestations and systemic symptoms in patients with lupus
  • Weigh treatment considerations in patients with lupus, including lupus in pregnancy and lupus nephritis
  • Evaluate indications and adverse effects of medications used to treat lupus
  • Appreciate health disparities that contribute to outcomes in lupus
  • Recognize the immunology and pathophysiology that drives the clinical manifestations seen in lupus
  • Address health maintenance considerations specific to patients with lupus


NOTE: It was recently discovered that the correct answer for question #6 is designated incorrectly in this activity. The correct answer for question #6 is answer option C; however, the system is recognizing answer option A as the correct answer. Please submit answer option A as the answer for this question. We apologize for this error.

Registration Fees

  • Members: $50 
  • Non-Members: $50
  • FIT Members: $25
  • FIT Non-Members: $50
  • Program Director Members: $25 (please email to receive a discount code for the reduced rate)

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this enduring material for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Claim MOC Points
Select the MOC checkbox to claim MOC points equal to the number of CME hours claimed. MOC points are submitted to ABIM each day at 11:30 PM EST. After points are submitted, ABIM will not accept changes. Check the ABIM Physician Portal 24 - 48 hours after submission to verify your MOC points are reflected.

Faculty and Disclosures

ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.

Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options, or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

The faculty reported the following disclosures.

  • Sarah Chisolm, MD, MPH - No relevant financial relationships to disclose
  • Megan Clowse, MD, MPH - UCB5, Pfizer2, Janssen2
  • Jason Cobb, MD - Abbvie2, MedImmune2, American Society of Nephrology2
  • Mary Anne Dooley, MD, MPH - GSK5,8, Lupus Foundation of America6, Aurinia5, Biogenidek5, UCB5, EMD Serono5, Medimmune5, Lily5, Genentec5, Lupus Clinical Trials Consortium6, BMS9
  • Candace Feldman, MD, MPH - Pfizer2
  • Joanne Michelle Kahlenberg, MD, PhD - No relevant financial relationships to disclose
  • Karen Law, MD - No relevant financial relationships to disclose
  • S. Sam Lim, MD, MPH - No relevant financial relationships to disclose
  • Amanda Sammut, MD - No relevant financial relationships to disclose

Corporate Support

The production of this activity was supported by Grant Number 1 CPIMP141065-01-00 from the U.S. Department of Health and Human Services Office of Minority Health (HHS, OMH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the HHS, OMH. No commercial support was obtained.